Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-24 @ 2:32 PM
NCT ID:
NCT00328159
Eligibility Criteria:
Inclusion Criteria:
* Patient with an enzyme deficiency of carnitine palmitoyltransferase 1 (CPT1), carnitine-acylcarnitine translocase (CAT), carnitine palmitoyltransferase 2 (CPT2), very-long chain acyl-CoA dehydrogenase (VLCAD), L-3-hydroxy-acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (MTP).
* Covered by health and social insurance
* Written informed consent
Exclusion Criteria:
* Patient affected with FAO dysfunction secondary to other cause (e.g. mitochondrial respiratory chain disorders)
* Patient with suspected FAO disorder that has not been proven (by enzymatic or molecular test)
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00328159
Study Brief:
Protocol Section:
NCT00328159